Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA‐C)

Paul J. Clark; Patricia C. Valery; Simone I. Strasser; Martin Weltman; Alex Thompson; Miriam Levy; Barbara Leggett; Amany Zekry; Julian Rong; Marie Sinclair; Jacob George; William Sievert; Gerry MacQuillan; Edmund Tse; Amanda Nicoll; Amanda Wade; Wendy Cheng; Stuart K. Roberts

doi:10.1111/dar.13914

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Alcohol use is common in patients with chronic hepatitis C virus (HCV) infection. We examined the impact of alcohol use on direct-acting antiviral (DAA) therapy outcome and the clinical course of liver disease and 2-year survival for patients receiving HCV DAA therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Clark et al. (2024) studied this question.

synapsesocial.com/papers/68e5daeeb6db643587570fca https://doi.org/10.1111/dar.13914

View Full Paper

Ask AI

Bookmark

Share

Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA‐C)

Ask about this paper

Abstract

Discussion

Cite This Study

Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA‐C)

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading